Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Pulse Biosciences (PLSE) Return on Equity (2020 - 2025)

Pulse Biosciences (PLSE) has 6 years of Return on Equity data on record, last reported at 0.84% in Q4 2025.

  • For Q4 2025, Return on Equity changed N/A year-over-year to 0.84%; the TTM value through Dec 2025 reached 0.84%, changed N/A, while the annual FY2025 figure was 0.74%, N/A changed from the prior year.
  • Return on Equity reached 0.84% in Q4 2025 per PLSE's latest filing, down from 0.21% in the prior quarter.
  • Across five years, Return on Equity topped out at 7.9% in Q1 2023 and bottomed at 29.69% in Q4 2022.
  • Average Return on Equity over 5 years is 2.32%, with a median of 1.17% recorded in 2021.
  • Peak YoY movement for Return on Equity: crashed -2829bps in 2022, then soared 2882bps in 2023.
  • A 5-year view of Return on Equity shows it stood at 1.4% in 2021, then crashed by -2018bps to 29.69% in 2022, then skyrocketed by 97bps to 0.87% in 2023, then rose by 1bps to 0.87% in 2024, then grew by 4bps to 0.84% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Equity were 0.84% in Q4 2025, 0.21% in Q3 2025, and 0.13% in Q2 2025.